U.S. Pharmaceuticals & Biotech Undervalued Small Caps

Zevra Therapeutics

Market Cap: US$471.8m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Abeona Therapeutics

Market Cap: US$276.4m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

SIGA Technologies

Market Cap: US$471.9m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Niagen Bioscience

Market Cap: US$511.8m

Operates as a bioscience company engages in developing healthy aging products.

MiMedx Group

Market Cap: US$888.6m

Develops and distributes placental tissue allografts for various sectors of healthcare.